Tradestie Institutional Equity Comparison Engine
CING vs CDIO โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
CING Overall Edge
CING Captures Institutional Edge (2โ1 Pillars ยท 4โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Cingulate Inc. Common Stock (CING) driven by superior Momentum & Technical, Options & Structure while CDIO counters with relative strength in Growth & Margin. Fundamentally, CING trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus CDIO at N/M Forward P/E and -42649.8% operating margin (+25.7% YoY). In options structure, CING sits in BREAKDOWN (16th %ile IV; Dealer Gamma Walls on Pro) against CDIO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
CING N/M vs CDIO N/M Fwd P/E
Growth & Margin Winner
CDIO
Op Margin 0.0% vs -42649.8% ยท YoY +0.0% vs +25.7%
Momentum & Technical Winner
CING
1Y +36.4% vs -48.7% ยท 52W Pos 18% vs 11%
Options & Structure Winner
CING
BREAKDOWN (16th %ile IV) vs UNCLASSIFIED (N/A IV)
CING
NASDAQ
Cingulate Inc. Common Stock
Pharmaceutical Preparations
$4.76
+26.93% 1D
Market Cap
$62.5M
1M Return
+9.17%
1Y Return
+36.39%
Forward P/E
N/M
Unified AI Score
44.8 / 100
HOLD
Tech 31.0
Fund 50.0
Flow 67.0
Mom 60.0
CDIO
NASDAQ
Cardio Diagnostics Holdings Inc. Common stock
In Vitro & In Vivo Diagnostic Substances
$1.75
-2.23% 1D
Market Cap
$5.6M
1M Return
+6.71%
1Y Return
-48.68%
Forward P/E
N/M
Unified AI Score
39.4 / 100
SELL
Tech 20.0
Fund 35.0
Flow 50.0
Mom 44.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
CING +36.39%
CDIO -48.68%
Spread: +85.07 pp (CING Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
CING TTM Op. Margin: 0.0%
CDIO TTM Op. Margin: -42649.8%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CING vs CDIO. Trailing 12-month operating profitability (CING 0.0% vs CDIO -42649.8%) and valuation multiples (CING N/M vs CDIO N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | CING | CDIO | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $62.5M | $5.6M | Larger Scale | CING |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +0.0% | +25.7% | Higher Growth | CDIO |
| Operating Margin (TTM) Profitability | 0.0% | -42649.8% | Higher Margin | CING |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -198.7% | -93.5% | Higher ROE | CDIO |
| 52-Week Range Position Momentum | 18% ($3โ$12) | 11% ($1โ$8) | Stronger Trend | CING |
| Beta / 30D Volatility Risk Regime | 1.13ฮฒ ยท 117% Vol | 1.44ฮฒ ยท 56% Vol | Lower Realized Risk | CDIO |
| Unified Institutional Score Composite Signal | 44.8 / 100 (HOLD) | 39.4 / 100 (SELL) | Higher Composite | CING |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full CING vs CDIO Buy Guide
CING
BREAKDOWN
170d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
16th %ile
IV Regime
Compressed (<25th %ile)
CDIO
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither CING nor CDIO registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.